Octanate Lv (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a coagulation factor VIII concentrate presented as a sterile solution for intravenous use. It replaces deficient factor VIII in patients with hemophilia A, helping to control and prevent bleeding episodes. GNH USA supplies Octanate Lv as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octanate Lv is a recombinant factor VIII product that acts on the intrinsic pathway of the coagulation cascade for hemophilia A management.

- Hemophilia A (severe): Improves the frequency and severity of bleeding episodes and supports prophylactic therapy. - Hemophilia A (moderate or mild type of  ...  .... .... .... ... ... ... ... ... ... ... ... … .... ... ... ... … … … … … … … … … … … … … … … … … … … … … … … … … … … …… … … … … ... … … … … … … … …… … … … … … … … … -   ...  … …  .... … … … … … … … … … … … … … … … …